1887

Abstract

Viperin is a gene with a broad spectrum of antiviral functions and various mechanisms of action. The role of viperin in herpes simplex virus type 1 (HSV-1) infection is unclear, with conflicting data in the literature that is derived from a single human cell type. We have addressed this gap by investigating viperin during HSV-1 infection in several cell types, spanning species and including immortalized, non-immortalized and primary cells. We demonstrate that viperin upregulation by HSV-1 infection is cell-type-specific, with mouse cells typically showing greater increases compared with those of human origin. Further, overexpression and knockout of mouse, but not human viperin significantly impedes and increases HSV-1 replication, respectively. In primary mouse fibroblasts, viperin upregulation by infection requires viral gene transcription and occurs in a predominantly IFN-independent manner. Further we identify the N-terminal domain of viperin as being required for the anti-HSV-1 activity. Interestingly, this is the region of viperin that differs most between mouse and human, which may explain the apparent species-specific activity against HSV-1. Finally, we show that HSV-1 virion host shutoff (vhs) protein is a key viral factor that antagonises viperin in mouse cells. We conclude that viperin can be upregulated by HSV-1 in mouse and human cells, and that mouse viperin has anti-HSV-1 activity.

Funding
This study was supported by the:
  • australian research council (Award DP190101325)
    • Principle Award Recipient: DavidC Tscharke
  • national health and medical research council (Award GNT1126599)
    • Principle Award Recipient: DavidC Tscharke
  • national health and medical research council (Award GNT1162025)
    • Principle Award Recipient: SiMing Man
  • national health and medical research council (Award GNT1104329)
    • Principle Award Recipient: DavidC Tscharke
  • This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001638
2021-08-18
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/102/8/jgv001638.html?itemId=/content/journal/jgv/10.1099/jgv.0.001638&mimeType=html&fmt=ahah

References

  1. Paludan SR, Bowie AG, Horan KA, Fitzgerald KA. Recognition of herpesviruses by the innate immune system. Nat Rev Immunol 2011; 11:143–154 [View Article] [PubMed]
    [Google Scholar]
  2. Paladino P, Mossman KL. Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response. J Interferon Cytokine Res 2009; 29:599–607 [View Article] [PubMed]
    [Google Scholar]
  3. Su C, Zhan G, Zheng C. Evasion of host antiviral innate immunity by HSV-1, an update. Virol J 2016; 13:38 [View Article] [PubMed]
    [Google Scholar]
  4. McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A. Type I interferons in infectious disease. Nat Rev Immunol 2015; 15:87–103 [View Article] [PubMed]
    [Google Scholar]
  5. Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol 2014; 32:513–545 [View Article] [PubMed]
    [Google Scholar]
  6. Mossman KL, Macgregor PF, Rozmus JJ, Goryachev AB, Edwards AM et al. Herpes simplex virus triggers and then disarms a host antiviral response. J Virol 2001; 75:750–758 [View Article] [PubMed]
    [Google Scholar]
  7. Nicholl MJ, Robinson LH, Preston CM. Activation of cellular interferon-responsive genes after infection of human cells with herpes simplex virus type 1. J Gen Virol 2000; 81:2215–2218 [View Article] [PubMed]
    [Google Scholar]
  8. Boudinot P, Riffault S, Salhi S, Carrat C, Sedlik C et al. Vesicular stomatitis virus and pseudorabies virus induce a vig1/cig5 homologue in mouse dendritic cells via different pathways. J Gen Virol 2000; 81:2675–2682 [View Article] [PubMed]
    [Google Scholar]
  9. Chin KC, Cresswell P. Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci U S A 2001; 98:15125–15130 [View Article] [PubMed]
    [Google Scholar]
  10. Helbig KJ, Lau DTY, Semendric L, Harley HAJ, Beard MR. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 2005; 42:702–710 [View Article] [PubMed]
    [Google Scholar]
  11. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441:101–105 [View Article] [PubMed]
    [Google Scholar]
  12. Olofsson PS, Jatta K, Wagsater D, Gredmark S, Hedin U et al. The antiviral cytomegalovirus inducible gene 5/viperin is expressed in atherosclerosis and regulated by proinflammatory agents. Arterioscler Thromb Vasc Biol 2005; 25:6e113
    [Google Scholar]
  13. Seo JY, Yaneva R, Cresswell P. Viperin: a multifunctional, interferon-inducible protein that regulates virus replication. Cell Host Microbe 2011; 10:534–539 [View Article]
    [Google Scholar]
  14. Severa M, Coccia EM, Fitzgerald KA. Toll-like receptor-dependent and -independent viperin gene expression and counter-regulation by PRDI-binding factor-1/BLIMP1. J Biol Chem 2006; 281:26188–26195 [View Article] [PubMed]
    [Google Scholar]
  15. Zhu H, Cong JP, Shenk T. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. Proc Natl Acad Sci U S A 1997; 94:13985–13990 [View Article] [PubMed]
    [Google Scholar]
  16. Duschene KS, Broderick JB. Viperin: a radical response to viral infection. Biomol Concepts 2012; 3:255–266 [View Article] [PubMed]
    [Google Scholar]
  17. Hinson ER, Cresswell P. The N-terminal amphipathic alpha-helix of viperin mediates localization to the cytosolic face of the endoplasmic reticulum and inhibits protein secretion. J Biol Chem 2009; 284:4705–4712 [View Article]
    [Google Scholar]
  18. Helbig KJ, Eyre NS, Yip E, Narayana S, Li K et al. The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A. Hepatology 2011; 54:1506–1517 [View Article] [PubMed]
    [Google Scholar]
  19. Teng TS, Foo SS, Simamarta D, Lum FM, Teo TH et al. Viperin restricts chikungunya virus replication and pathology. J Clin Invest 2012; 122:4447–4460 [View Article] [PubMed]
    [Google Scholar]
  20. Duschene KS, Broderick JB. The antiviral protein viperin is a radical SAM enzyme. FEBS Lett 2010; 584:1263–1267 [View Article] [PubMed]
    [Google Scholar]
  21. Gizzi AS, Grove TL, Arnold JJ, Jose J, Jangra RK et al. A naturally occurring antiviral ribonucleotide encoded by the human genome. Nature 2018; 558:610–614 [View Article] [PubMed]
    [Google Scholar]
  22. Upadhyay AS, Vonderstein K, Pichlmair A, Stehling O, Bennett KL et al. Viperin is an iron-sulfur protein that inhibits genome synthesis of tick-borne encephalitis virus via radical SAM domain activity. Cell Microbiol 2014; 16:834–848 [View Article] [PubMed]
    [Google Scholar]
  23. Helbig KJ, Beard MR. The role of viperin in the innate antiviral response. J Mol Biol 2014; 426:1210–1219 [View Article] [PubMed]
    [Google Scholar]
  24. Van der Hoek KH, Eyre NS, Shue B, Khantisitthiporn O, Glab-Ampi K et al. Viperin is an important host restriction factor in control of Zika virus infection. Sci Rep 2017; 7:4475 [View Article] [PubMed]
    [Google Scholar]
  25. Seo JY, Yaneva R, Hinson ER, Cresswell P. Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity. Science 2011; 332:1093–1097 [View Article]
    [Google Scholar]
  26. Shen G, Wang K, Wang S, Cai M, Li ML et al. Herpes simplex virus 1 counteracts viperin via its virion host shutoff protein UL41. J Virol 2014; 88:12163–12166 [View Article] [PubMed]
    [Google Scholar]
  27. Boehme KW, Singh J, Perry ST, Compton T. Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B. J Virol 2004; 78:1202–1211 [View Article] [PubMed]
    [Google Scholar]
  28. Zheng C, Su C. Herpes simplex virus 1 infection dampens the immediate early antiviral innate immunity signaling from peroxisomes by tegument protein VP16. Virol J 2017; 14:35 [View Article] [PubMed]
    [Google Scholar]
  29. Rice SA, Knipe DM. Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27. J Virol 1990; 64:1704–1715 [View Article] [PubMed]
    [Google Scholar]
  30. Russell TA, Tscharke DC. Lytic promoters express protein during herpes Simplex virus latency. PLoS Pathog 2016; 12:e1005729 [View Article]
    [Google Scholar]
  31. McCarthy AM, McMahan L, Schaffer PA. Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J Virol 1989; 63:18–27 [View Article] [PubMed]
    [Google Scholar]
  32. Read GS, Karr BM, Knight K. Isolation of a herpes simplex virus type 1 mutant with a deletion in the virion host shutoff gene and identification of multiple forms of the vhs (UL41) polypeptide. J Virol 1993; 67:7149–7160 [View Article] [PubMed]
    [Google Scholar]
  33. Crosse KM, Monson EA, Dumbrepatil AB, Smith M, Tseng YY et al. Viperin binds STING and enhances the type-I interferon response following dsDNA detection. Immunology & Cell Biology 2020; 99:373–391
    [Google Scholar]
  34. Garvey CE, McGowin CL, Foster TP. Development and evaluation of SYBR Green-I based quantitative PCR assays for herpes simplex virus type 1 whole transcriptome analysis. J Virol Methods 2014; 201:101–111 [View Article] [PubMed]
    [Google Scholar]
  35. Zenner HL, Mauricio R, Banting G, Crump CM. Herpes simplex virus 1 counteracts tetherin restriction via its virion host shutoff activity. J Virol 2013; 87:13115–13123 [View Article] [PubMed]
    [Google Scholar]
  36. Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods 2014; 11:783–784 [View Article] [PubMed]
    [Google Scholar]
  37. Hardwicke MA, Sandri-Goldin RM. The herpes simplex virus regulatory protein ICP27 contributes to the decrease in cellular mRNA levels during infection. J Virol 1994; 68:4797–4810 [View Article] [PubMed]
    [Google Scholar]
  38. Taddeo B, Zhang W, Roizman B. Role of herpes simplex virus ICP27 in the degradation of mRNA by virion host shutoff RNase. J Virol 2010; 84:10182–10190 [View Article] [PubMed]
    [Google Scholar]
  39. Tang HB, Lu ZL, Wei XK, Zhong TZ, Zhong YZ et al. Viperin inhibits rabies virus replication via reduced cholesterol and sphingomyelin and is regulated upstream by TLR4. Sci Rep 2016; 6:30529 [View Article] [PubMed]
    [Google Scholar]
  40. Szretter KJ, Brien JD, Thackray LB, Virgin HW, Cresswell P et al. The interferon-inducible gene viperin restricts West Nile virus pathogenesis. J Virol 2011; 85:11557–11566 [View Article] [PubMed]
    [Google Scholar]
  41. Stirnweiss A, Ksienzyk A, Klages K, Rand U, Grashoff M et al. IFN regulatory factor-1 bypasses IFN-mediated antiviral effects through viperin gene induction. J Immunol 2010; 184:5179–5185 [View Article] [PubMed]
    [Google Scholar]
  42. Collins SE, Noyce RS, Mossman KL. Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol 2004; 78:1706–1717 [View Article] [PubMed]
    [Google Scholar]
  43. Lin R, Noyce RS, Collins SE, Everett RD, Mossman KL. The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J Virol 2004; 78:1675–1684 [View Article] [PubMed]
    [Google Scholar]
  44. Shahnazaryan D, Khalil R, Wynne C, Jefferies CA et al. Herpes simplex virus 1 targets IRF7 via ICP0 to limit type I IFN induction. Sci Rep 2020; 10:22216 [View Article] [PubMed]
    [Google Scholar]
  45. Tsitoura E, Thomas J, Cuchet D, Thoinet K, Mavromara P et al. Infection with herpes simplex type 1-based amplicon vectors results in an IRF3/7-dependent, TLR-independent activation of the innate antiviral response in primary human fibroblasts. J Gen Virol 2009; 90:2209–2220 [View Article] [PubMed]
    [Google Scholar]
  46. Xing J, Ni L, Wang S, Wang K, Lin R et al. Herpes simplex virus 1-encoded tegument protein VP16 abrogates the production of beta interferon (IFN) by inhibiting NF-κB activation and blocking IFN regulatory factor 3 to recruit its coactivator CBP. J Virol 2013; 87:9788–9801 [View Article] [PubMed]
    [Google Scholar]
  47. Hinson ER, Cresswell P. The antiviral protein, viperin, localizes to lipid droplets via its N-terminal amphipathic alpha-helix. Proc Natl Acad Sci U S A 2009; 106:20452–20457 [View Article]
    [Google Scholar]
  48. Tang YD, Na L, Zhu CH, Shen N, Yang F et al. Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum. J Virol 2014; 88:12296–12310 [View Article] [PubMed]
    [Google Scholar]
  49. Wang X, Hinson ER, Cresswell P. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2007; 2:96–105 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001638
Loading
/content/journal/jgv/10.1099/jgv.0.001638
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error